Real-world evidence of galcanezumab for migraine treatment in japan: a retrospective analysis

HIGHLIGHTS

• who: Tsubasa Takizawa from the Shinanomachi, Shinjukuu2011Ku, Tokyo, u20118582, Japan Department of, Keio University School of Medicine, have published the article: Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis, in the Journal: (JOURNAL)
• what: This study revealed the efficacy and safety of for migraineurs in Japan. also improved migraine-associated However despite a reduction in headaches without subsequent headache were reported in > 50% of the patients at 3 months. Only 51.9% of the patients in this study had CM.
• how: The authors conducted a single-center observational . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.